Nateglinide And Valsartan in Impaired Glucose Tolerance Outcomes Research - NAVIGATOR

Description:

The goal of the trial was to evaluate treatment with nateglinide (a short-acting insulin secretagogue), valsartan, or both among patients with impaired glucose tolerance.